12/20
Headlines

China Biologic Products Inc

Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

Mark Doerr03 mins

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was…

Read More

Small Cap Decliners: Vital Therapies (NASDAQ:VTL), China Biologic Products (NASDAQ:CBPO), Versartis (NASDAQ:VSAR), Theravance (NASDAQ:TBPH), VASCO Data Security International(NASDAQ:VDSI)

Kevin Long02 mins

Vital Therapies currently has a Zacks Rank #3 (Hold). Vital Therapies Inc (NASDAQ:VTL) stock performance was -5.83% in last session and finished the day at $30.52. Traded volume was 94.00K shares in the last session and the average volume of the stock remained 96.31K shares. China Biologic Products (CBPO) shares fell in late trading after…

Read More
Gilead Sciences GILD NASDAQ:GILD

Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

Kristen Barton03 mins

InterMune, Inc. (NASDAQ:ITMN) on 27 May 2014 announced that it has resubmitted its pirfenidone New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2010. Pirfenidone is being developed for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF). InterMune Inc…

Read More
Gilead Sciences GILD NASDAQ:GILD

New Highs: China Biologic Products Inc (NASDAQ:CBPO), Centene Corp (NYSE:CNC), LifePoint Hospitals, Inc. (NASDAQ:LPNT), Universal Health Services, Inc. (NYSE:UHS)

Jayne Crisman02 mins

Jefferies Group assumed coverage on shares of China Biologic Products (NASDAQ:CBPO) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $52.00 price objective on the stock. China Biologic Products Inc (NASDAQ:CBPO) stock performance was 1.37% in last session and finished the day at $43.67. Traded volume was 59,338.00million…

Read More